A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of paliperidone extended-release
(ER; designed to slowly release a drug in the body over an extended period of time) tablets
in participants with schizophrenia (psychiatric disorder with symptoms of emotional
instability, detachment from reality, often with delusions [a false belief held in the face
of strong differing evidence, especially as a symptom of psychiatric disorder] and
hallucinations [imagining things], and withdrawal into the self) who were not satisfied with
other prior antipsychotics (agents that control agitated psychotic behavior, alleviate acute
psychotic states, reduce psychotic symptoms, and exert a quieting effect; olanzapine,
quetiapine and risperidone) they had been taking. The safety and tolerability of paliperidone
ER tablets will also be assessed.